Roderick Wong - 14 Jun 2021 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director, 10%+ Owner
Signature
/s/ Sara Turken, as attorney-in-fact
Issuer symbol
RCKT
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
4
Filing time
16 Jun 2021, 20:06:26 UTC
Next filing
17 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +15,295 $0.000000 15,295 14 Jun 2021 Common Stock 15,295 $47.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 15,295 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 14, 2022.